Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation



Zulkifly, Hanis, Cheli, Paola, Lutchman, Ivana, Bai, Ying, Lip, Gregory YH ORCID: 0000-0002-7566-1626 and Lane, Deirdre A ORCID: 0000-0002-5604-9378
(2020) Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation Thrombosis Research, 192. pp. 12-20. ISSN 0049-3848, 1879-2472

[thumbnail of TTR vs ethnicity_TR_REVISED_CLEAN_SUBMITTED.docx] Text
TTR vs ethnicity_TR_REVISED_CLEAN_SUBMITTED.docx - Author Accepted Manuscript

Download (209kB)

Abstract

Background: Efficacy and safety of vitamin K antagonists (VKAs) is optimised in atrial fibrillation (AF) patients when the International Normalised Ratio (INR) is 2.0–3.0. Anticoagulation control comparing different ethnic groups is limited, although epidemiological studies suggest poorer INR control in non-white cohorts. Methods: VKA control was assessed retrospectively by time-in-the-therapeutic range (TTR) (Rosendaal method) and percentage INR-in-range (PINRR) in 991 White, Afro-Caribbean and South-Asian AF patients [overall mean (SD) age 71.6 (9.4) years; 55% male; mean (SD) CHA<inf>2</inf>DS<inf>2</inf>-VASc score 3.4 (1.6)] over a median (IQR) follow-up of 5.2 (3.2–7.0) years. Results: Compared to Whites, mean (SD) TTR and PINRR were significantly lower in South-Asians [TTR 67.9% vs. 60.5%; PINRR 58.8% vs. 51.6%, respectively] and Afro-Caribbeans [TTR 67.9% vs. 61.3%; PINRR 58.8% vs. 53.1%, respectively], despite similar INR monitoring intensity. Logistic regression revealed non-white ethnicity [OR 2.62; 95% Confidence Interval [CI] (1.67–4.10) and OR 3.47 (1.44–8.34)] and anaemia [OR 1.65 (1.00–2.70) and OR 6.27 (1.89–20.94)] as independent predictors of both TTR and PINRR < 70%, respectively. At follow-up, 329 (33.2%) patients experienced ≥1 major adverse clinical event. Cardiovascular hospitalisation was significantly higher among South-Asians (32.3%) compared to the Whites and Afro-Caribbeans (21.3% vs 25.6% respectively). Conclusions: Ethnic disparities in quality of anticoagulation control are evident, with South-Asians and Afro-Caribbeans having poorer control compared to Whites, despite similar intensity INR monitoring. Non-white ethnicity remained the strongest independent predictor of poor TTR and PINRR. Interventions to improve anticoagulation control need to be implemented, particularly targeting ethnic minority patients.

Item Type: Article
Uncontrolled Keywords: Anticoagulation control, Atrial fibrillation, Ethnicity, Stroke prevention, Vitamin K antagonist
Depositing User: Symplectic Admin
Date Deposited: 15 May 2020 10:40
Last Modified: 01 Mar 2026 04:31
DOI: 10.1016/j.thromres.2020.04.001
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3087256
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.